Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland

Thyroid disorders as predictors of cemiplimab efficacy in recurrent/metastatic cervical cancer: real-world evidence from Poland

IntroductionImmune checkpoint inhibitors have improved survival in patients with recurrent or metastatic cervical cancer (r/mCC), yet reliable predictors of treatment efficacy remain undefined. Immune-related adverse events (irAEs) have been suggested as potential predictors of response, but evidenc...

Full description

Saved in:
Bibliographic Details
Main Authors: Renata Pacholczak-Madej, Maja Lisik-Habib, Radosław Mądry, Monika Szarszewska, Zuzanna Borysiewicz, Katarzyna Gabalewicz, Ewa Iwańska, Wiktor Szatkowski, Mirosława Puskulluoglu, Jerzy Jakubowicz, Paweł Blecharz
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
cemiplimab
uterine cervical neoplasms
thyroid diseases
immune checkpoint inhibitors
immune-related adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1604826/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1604826/full

Similar Items